Skip to main content
Top
Published in: Acta Diabetologica 1/2013

01-02-2013 | Original Article

Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting

Authors: C. B. Giorda, M. F. Mulas, V. Manicardi, C. Suraci, P. Guida, L. Marafetti, E. Nada, S. Gentile

Published in: Acta Diabetologica | Issue 1/2013

Login to get access

Abstract

The time to achieve good metabolic control after diagnosis is essential for type 2 diabetes patients because it can influence long-term prognosis. This study aimed to elucidate the predictive role of several clinical and organization factors in normalizing metabolism within 6 months. A multi-centered, retrospective, observational study on 960 patients, with diabetes duration of 12 months or less, consecutively seen in 123 Italian clinics, was undertaken. Information about clinic’s organization, along with data abstracted from medical records at enrollment (first visit) and after 6 months (follow-up visit), was collected. At 6 months, HbA1c dropped by −3.1 ± 2.2 points in those who achieved HbA1c <7 % (responders), whereas in non-responders (HbA1c ≥7 %), the mean reduction was −1.8 ± 1.9. The intervention markedly reduced lipids, blood pressure, BMI, and waist circumference, especially in responders. The presence of a diabetes team correlated with a likelihood of HbA1c normalization (OR 1.94, 1.17–3.22). By contrast, indicators of advanced disease such as previous retinopathy (0.53, 0.29–0.98), use of secretagogues (0.40, 0.25–0.64), high levels of HbA1c at first visit and related insulin use emerged as adverse factors. Early detection of diabetes, along with human resources and organization, was found to play a crucial role in rapidly attaining good metabolic control.
Appendix
Available only for authorised users
Literature
1.
go back to reference The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653CrossRef The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653CrossRef
2.
go back to reference Holman RR, Sanjoy KP, Bethel MA, Matthews DR, Neil HAW (2008) 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMedCrossRef Holman RR, Sanjoy KP, Bethel MA, Matthews DR, Neil HAW (2008) 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMedCrossRef
3.
go back to reference Gæde P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591PubMedCrossRef Gæde P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591PubMedCrossRef
4.
go back to reference Ceriello A, Ihnat MA, Thorpe JE (2009) Clinical review 2: the “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab (United States) 94(2):410–415CrossRef Ceriello A, Ihnat MA, Thorpe JE (2009) Clinical review 2: the “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab (United States) 94(2):410–415CrossRef
5.
go back to reference De Micheli A (2008) Italian standards for diabetes mellitus 2007: executive summary Diabete Italia, AMD Associazione Medici Diabetologi, SID Societa` Italiana di Diabetologia. Acta Diabetol 45:107–127CrossRef De Micheli A (2008) Italian standards for diabetes mellitus 2007: executive summary Diabete Italia, AMD Associazione Medici Diabetologi, SID Societa` Italiana di Diabetologia. Acta Diabetol 45:107–127CrossRef
6.
go back to reference American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diabetes Care 33 (Supplement, January) American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diabetes Care 33 (Supplement, January)
7.
go back to reference White NH, Sun W, Cleary PA et al (2008) Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol (United States) 126(12):1707–1715CrossRef White NH, Sun W, Cleary PA et al (2008) Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol (United States) 126(12):1707–1715CrossRef
8.
go back to reference Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM (2006) The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55(12):3556–3565. ISSN: 0012-1797 Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM (2006) The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55(12):3556–3565. ISSN: 0012-1797
9.
go back to reference Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y (2009) IMPROVE Study Group Expert Panel. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. Int J Clin Pract 63(3):522–531. Epub 2009 Jan 27 Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y (2009) IMPROVE Study Group Expert Panel. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. Int J Clin Pract 63(3):522–531. Epub 2009 Jan 27
10.
go back to reference Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, Stehouwer CD, Bouter LM, Heine RJ (2003) Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the HOOM screening study. Diabetes Care 26(9):2604–2608PubMedCrossRef Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, Stehouwer CD, Bouter LM, Heine RJ (2003) Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the HOOM screening study. Diabetes Care 26(9):2604–2608PubMedCrossRef
11.
go back to reference Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819PubMedCrossRef Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819PubMedCrossRef
12.
go back to reference Giorda CB, Guida P, Avogaro A, Cortese C, Mureddu GF, Corsini A, Comaschi MA, Manzato E, Volpe M, Zito GB, Medea G, Ventriglia G, Titta G, Riccardi G, EFFECTUS Steering Committee (2009) Association of physicians’ accuracy in recording with quality of care in cardiovascular medicine. Eur J Cardiovasc Prev Rehabil 16(6):722–728 Giorda CB, Guida P, Avogaro A, Cortese C, Mureddu GF, Corsini A, Comaschi MA, Manzato E, Volpe M, Zito GB, Medea G, Ventriglia G, Titta G, Riccardi G, EFFECTUS Steering Committee (2009) Association of physicians’ accuracy in recording with quality of care in cardiovascular medicine. Eur J Cardiovasc Prev Rehabil 16(6):722–728
13.
go back to reference Engelgau MM, Narayan KM, Herman WH (2000) Screening for type 2 diabetes. Diabetes Care 23:1563–1580PubMedCrossRef Engelgau MM, Narayan KM, Herman WH (2000) Screening for type 2 diabetes. Diabetes Care 23:1563–1580PubMedCrossRef
14.
go back to reference Gnavi R, Picariello R, la Karaghiosoff L, Costa G, Giorda C (2009) Determinants of quality in diabetes care process: the population-based Torino Study. Diabetes Care 32(11):1986–1992 [Epub 2009 Aug 12] Gnavi R, Picariello R, la Karaghiosoff L, Costa G, Giorda C (2009) Determinants of quality in diabetes care process: the population-based Torino Study. Diabetes Care 32(11):1986–1992 [Epub 2009 Aug 12]
15.
go back to reference Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C (2005) Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 28(3):600–606PubMedCrossRef Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C (2005) Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 28(3):600–606PubMedCrossRef
16.
go back to reference Mc Allister FA, Majumdar SR, Eurich DT, Johnson JA (2007) The effect of specialist care within the first year on subsequent outcomes in 24232 adults with new-onset diabetes mellitus: population-based cohort study. Qual Saf Health Care 16:6–11CrossRef Mc Allister FA, Majumdar SR, Eurich DT, Johnson JA (2007) The effect of specialist care within the first year on subsequent outcomes in 24232 adults with new-onset diabetes mellitus: population-based cohort study. Qual Saf Health Care 16:6–11CrossRef
17.
go back to reference Levetan CS, Salas J, Wilets IF, Zumoff B (1995) Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 99:22–28PubMedCrossRef Levetan CS, Salas J, Wilets IF, Zumoff B (1995) Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 99:22–28PubMedCrossRef
18.
go back to reference Koproski J, Pretto Z, Poretsky L (1997) Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 20:1553–1555PubMedCrossRef Koproski J, Pretto Z, Poretsky L (1997) Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 20:1553–1555PubMedCrossRef
19.
go back to reference Phillips LS, Branch WT Jr, Cook CB, Doyle JP (2001) Clinical inertia. Ann Intern Med 135:825–834PubMed Phillips LS, Branch WT Jr, Cook CB, Doyle JP (2001) Clinical inertia. Ann Intern Med 135:825–834PubMed
20.
go back to reference Larme AC, Pugh JA (2001) Evidence-based guidelines meet the real world the case of diabetes care. Diabetes Care 24(10):1728–1733PubMedCrossRef Larme AC, Pugh JA (2001) Evidence-based guidelines meet the real world the case of diabetes care. Diabetes Care 24(10):1728–1733PubMedCrossRef
Metadata
Title
Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting
Authors
C. B. Giorda
M. F. Mulas
V. Manicardi
C. Suraci
P. Guida
L. Marafetti
E. Nada
S. Gentile
Publication date
01-02-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-012-0431-0

Other articles of this Issue 1/2013

Acta Diabetologica 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.